Product Groups
Contact Details
  • Rongda Pharm & Chem Co.,Ltd

  • Ms.Mandy
  • Tel: 86-571-28281880
  • Fax: 86-571-28281887
  • Industrial Park, Xiaoshu, Anji, Zhejiang, China.
Home>

News

  • Traditional Chinese medicine export needs a sound standard system
    Over the years, because of foreign "green barriers", traditional Chinese medicine export repeatedly rebuffed. China as a traditional Chinese medicine major power, Chinese medicine export volume accounts only for 3% to 5% in the world's traditional Chinese medicine market. Even more worrying is that foreign pharmaceutical companies import medicinal extracts from China, and do further processing in abroad, then turn it into " foreign Chinese medicine "and resold in  high price. ......
    Oct 17, 2013
  • Exploration of the main solution to increase Chinese API export
    According to The 20132017 Report of Demand and Supply and Competition in API market of Chinese Pharmaceutical Industry, the export of Chinese API was $12,112 thousand during the first half year of 2013, increasing by 3.08% and the accurate amount was 3,339.3 million tons, increasing by 7.46%. While the average export price decreased by 4.07%, the increasing rate was still low. Nowadays, as the oversupply and the fierce competition in the market, as well as the slow economy recove......
    Oct 15, 2013
  • CPhI, ICSE & BioPh China 2013 promotes the prosperity and development of the world pharmaceutical trade
    In recent years, China's BPC industry has developed rapidly and China has become the world's largest BPC producer and exporter. Currently, the foreign trade is still at the stage of constant growth with promising prospect. The constant progress of new medical system reform and supporting measures has promoted the industrial structure change of China's pharmaceutical manufacturing industry, which brings great opportunities for China's pharmaceutical industry. The prosperous industrial d......
    Oct 14, 2013
  • Pharmaceutical companies should choose the appropriate field to enter
    In recent years, with the continuous development of the pharmaceutical industry, the pharmaceutical trade export has become a focus of concern to the industry. Export trade appeared serious polarization, the developed market remains in the doldrums, and the demand of emerging market is strong. According to relevant statistics show that the first half of this year the number of China's pharmaceutical products export to Europe and the United States, Japan and other developed market......
    Oct 12, 2013
  • The analysis of China's API export in the first three quarters of 2013
    As a major exporter of API, China encountered many difficulties in entering the market in Europe and the United States. Recently, China Chamber of Commerce for Import of Medicine &Health Products (Hereinafter referred to as CCCMHPIE) introduced: the first half of the year, China's pharmaceutical import and export trade amounted to USD $43.237 billion. It’s Up 10.28% from a year earlier. But since the third quarter, China's API export to Europe and the United States perhaps will into......
    Oct 11, 2013
  • tsuka Pharmaceutical to buy US cancer firm Astex for $886m
    Japanese drugmaker Otsuka Pharmaceutical has agreed to acquire Astex Pharmaceuticals for $866m in an all-cash tender offer. Under the deal, Astex's fragment-based drug design technology called 'PYRAMID' will be integrated into Otsuka, which would strengthen its portfolio of cancer drugs. The move is expected to improve Otsuka's discovery and development of cancer drugs as well as research for potential central nervous system treatments. Astex's PYRAMID technology, which is a......
    Sep 16, 2013
  • Karo Bio reaches first milestone in Pfizer deal
    Swedish biotechnology firm Karo Bio (KARO) has achieved its first milestone in a research agreement with Pfizer for the development of drugs for treatment of autoimmune diseases. The achievement of milestone in the RORgamma project triggers the first milestone payment to Karo Bio. Under the research agreement, which started in December 2011, Pfizer agreed to provide full funding for the research costs and will have the sales rights to market any products that will be developed. ......
    Sep 16, 2013
  • Supernus launches Trokendi extended release formulation to treat epilepsy in US
    Specialty pharmaceutical company Supernus has launched Trokendi XR, its once-daily extended release formulation of topiramate, for the treatment of epilepsy in the US. As of now, Trokendi XR has been shipped to major wholesalers in the market, while the company's sales force is promoting the product to physicians. Supernus president and CEO Jack Khattar said, "Supernus is now a major player in epilepsy, offering two novel and differentiated products to patients." The antiepi......
    Sep 16, 2013
  • Forest Laboratories' ceftazidime/avibactam gets QIDP designation from US FDA
    US-based pharmaceutical manufacturer and marketer Forest Laboratories (FRX) has received qualified infectious disease product (QIDP) designation for its ceftazidime/avibactam drug from the US Food and Drug Administration (FDA). Currently the drug is in Phase III trials to investigate efficacy in treating patients with complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI), both serious Gram-negative bacterial infections. The drug will be used......
    Sep 16, 2013
  • Champions Oncology, Teva enter into new discovery and drug development deal
    Champions Oncology (Champions), a developer of advanced technology solutions and services to personalize the development and use of oncology drugs, has signed a new discovery and drug development partnership with Teva Pharmaceutical Industries (TEVA). Under the deal, Champions TumorGraft technology platform will be used to improve and speed up the clinical development of many oncology compounds of Teva. The partnership is aimed at identifying highly responsive cancer subtypes, and......
    Sep 16, 2013
 
Copyright © Rongda Pharm & Chem Co.,Ltd All rights reserved.     Powered by SnapExport
Quick Message